C12N 2830/50
Regulating rna stability, not being an intron
Official title: regulating RNA stability, not being an intron, e.g. poly A signal
C12N2830/50 (Regulating rna stability, not being an intron) appears on 321 US grants and 1,040 published applications in this corpus.
Search patents in C12N- Granted patents
- 321
- Published applications
- 1,040
- Assignees
- 513
- Inventors
- 2,282
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 1 |
| 2002 | 2 | 5 |
| 2003 | 3 | 18 |
| 2004 | 2 | 10 |
| 2005 | 2 | 14 |
| 2006 | 6 | 17 |
| 2007 | 7 | 4 |
| 2008 | 1 | 6 |
| 2009 | 5 | 3 |
| 2010 | 3 | 8 |
| 2011 | 6 | 8 |
| 2012 | 5 | 10 |
| 2013 | 11 | 6 |
| 2014 | 8 | 8 |
| 2015 | 5 | 22 |
| 2016 | 10 | 7 |
| 2017 | 9 | 21 |
| 2018 | 11 | 23 |
| 2019 | 11 | 27 |
| 2020 | 13 | 34 |
| 2021 | 12 | 69 |
| 2022 | 21 | 94 |
| 2023 | 30 | 116 |
| 2024 | 38 | 156 |
| 2025 | 48 | 196 |
| 2026 | 43 | 157 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions useful for treatment of Charcot-Marie-Tooth disease6 Oct 2026US 12,753,419 B2The Trustees of the University of Pennsylvania
- Engineered DNA molecule for coding RNA22 Sep 2026US 12,742,172 B2Rinuagene Biotechnology Co., Ltd.
- Gene therapy for macular degeneration11 Aug 2026US 12,702,721 B2University of Utah Research Foundation
- Gene editing methods for treating alpha-1 antitrypsin (AAT) deficiency4 Aug 2026US 12,697,400 B2Precision BioSciences, Inc.
- DNA origami encoding for gene expression and contransfection4 Aug 2026US 12,698,510 B2Technische Universität München
- Recombinant adeno-associated viral vectors for multipartite gene delivery and stargardt disease treatment8 Oct 2026US 2026/0306667 A1Abeona Therapeutics Inc.
- Modified adeno-associated virus vector and use thereof in treating neurological diseases8 Oct 2026US 2026/0306673 A1Genecombio Ltd.
- Expression cassette coding for vascular endothelial growth factor8 Oct 2026US 2026/0308618 A1Cornell University
- Retroviral vectors8 Oct 2026US 2026/0308619 A1UCL Business PLC
- Compositions comprising smyd1 and methods of use thereof8 Oct 2026US 2026/0308621 A1
Most cited
By later US patents
- Method for introducing and expressing RNA in animal cells143US 6,500,419 B1University of Maryland Biotechnology Institute · 2002
- Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen109US 9,669,089 B2CureVac AG · 2017
- Use of triplex structure DNA in transferring nucleotide sequences98US 6,682,907 B1Institut Pasteur · 2004
- Lentiviral vectors72US 6,207,455 B12001
- Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein68US 9,447,431 B2CureVac AG · 2016